In one paragraphArticle in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Flavio Beke *University of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK.ORCID 0000-0002-2294-0306 Joachim Hanna *University of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK.ORCID 0000-0002-2055-1462 Chrysa KapeniUniversity of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK.ORCID 0000-0003-0408-2106 Valentina CarbonaroUniversity of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK.ORCID 0000-0003-0915-6901 Nico MuellerUniversity of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK.
Sophie TrotterUniversity of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK.
Chandra ChilamakuriUniversity of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK.
Louise M O'BrienUniversity of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK.ORCID 0000-0002-8121-5374 Maike de la RocheUniversity of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK. maike.delaroche@cruk.cam.ac.uk.ORCID 0000-0002-0558-4119 Funding
Cancer Research UK (CRUK) A22257Cancer Research UK (CRUK) SEBINT-2024/100003Cancer Research UK (CRUK) studentship CRUK CIUKRI | Medical Research Council (MRC) MR/N013433/1Wellcome TrustWellcome Trust (WT) 107609/Z/15/ZWellcome Trust (WT) 227432/Z/23/Z
6 · The paper itselfAbstract
Indexed as
Calcium Channels, L-TypeHedgehog ProteinsSignal TransductionT-Lymphocytes, CytotoxicAnimalsCalciumCytotoxicity, ImmunologicHumansMiceReceptors, Antigen, T-CellZinc Finger Protein GLI1CalciumCalcium Channels, L-TypeHedgehog ProteinsReceptors, Antigen, T-CellZinc Finger Protein GLI1
Identifiers
PMID42260178
PMCPMC13354577
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390